How alcohol affects the progression of prostate cancer
The role for alcohol-induced Golgi disorganization in the progression of prostate cancer
This study is looking at how drinking alcohol over a long time might affect the growth of prostate cancer and whether stopping alcohol could help patients with this condition feel better and improve their treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-10675501 on NIH RePORTER |
What this research studies
This research investigates the impact of chronic alcohol consumption on the progression of prostate cancer. It explores the mechanisms by which alcohol may disrupt cellular structures, specifically the Golgi complex, and how this disruption could influence cancer advancement. The study aims to determine whether abstaining from alcohol could serve as a beneficial therapeutic intervention for patients with prostate cancer. By examining the cellular responses to alcohol, the research seeks to uncover potential pathways that could be targeted for treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with prostate cancer who have a history of chronic alcohol consumption.
Not a fit: Patients with prostate cancer who do not consume alcohol or have never consumed alcohol may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide insights into new therapeutic strategies for managing prostate cancer in patients who consume alcohol.
How similar studies have performed: While the specific mechanisms of alcohol's impact on prostate cancer are not extensively studied, related research has shown that alcohol consumption can influence cancer progression, suggesting potential for meaningful findings in this area.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Petrosyan, Armen — University of Nebraska Medical Center
- Study coordinator: Petrosyan, Armen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.